Iobenguane sulfate
Iobenguane sulfate (MIBG sulfate) acts as a high-affinity substrate for cholera toxin, inhibiting cellular mono (ADP-ribosylation) . Its radioiodinated form is a clinically established radiopharmaceutical for targeting and treating adrenergic tumors, such as neuroblastoma and pheochromocytoma, in both diagnostic imaging and therapeutic applications.
Product Specifications
CAS Number
87862-25-7
Product Name Alternative
Iobenguane, Iobenguane sulfate, Iobenguane Sulfate, mono (ADP-ribosylation), inhibit, MIBG, MIBG Sulfate, MIBG sulfate, Inhibitor, cytotoxic, adrenergic, antitumor, analogue, tumors, survival, proliferation
Field of Research
Neuroscience, Pharmacology & Drug Discovery
Purity
98.21% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (12.34 mM) ; DMSO:100 mg/mL (308.53 mM)
Smiles
OS (O) (=O) =O.NC (=N) NCc1cccc (I) c1.NC (=N) NCc1cccc (I) c1
Molecular Formula
C8H10IN3.1/2H2O4S
Molecular Weight
324.12
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
